+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07018024

Study of Prognosis and Treatment in Anti-Glomerular Basement Membrane Disease Using Patient Data and Biomarkers

Led by Region Skane · Updated on 2025-06-25

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying anti-glomerular basement membrane disease anti-GBM disease, a rare but severe condition also known as Goodpastures disease. This observational study aims to understand the prognosis of this disease by examining how different treatment options and disease severity at diagnosis affect outcomes. The study focuses on analyzing biomarkers in blood and urine, as well as the impact of initial treatment intensity on kidney function and patient survival. The study has two parts Arm A includes patients diagnosed between January 1, 2010, and December 31, 2027, with available data on their initial treatment. Arm B includes patients diagnosed at any time with available blood or urine samples from diagnosis and information about survival six months after diagnosis. Researchers will collect data on treatments involving corticosteroids, cytotoxic agents, and plasma exchange, and evaluate various autoantibodies and markers of kidney damage and inflammation. Participants will have their kidney function and survival monitored over time, with the primary outcome being kidney survival 12 months after diagnosis. Secondary outcomes include patient survival at six and 12 months. The study uses existing patient data and biological samples to better understand the disease prognosis and treatment effects. It is sponsored by Region Skane and is expected to continue until December 2028.

CONDITIONS

Brief Title

Anti-Glomerular Basement Membrane Disease

Research Team

M

Mårten Segelmark, MD, PhD, Professor

L

Linnéa Tyrberg, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here